Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMMB | AZN | AMGN | GILD | GSK |
| Company | Chemomab Therapeutics Ltd ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.6100 | 206.60 | 372.01 | 150.58 | 59.87 |
| High | 1.6100 | 207.69 | 377.00 | 153.26 | 60.05 |
| Low | 1.5000 | 204.05 | 371.39 | 150.09 | 59.33 |
| Latest | 1.5700 | 204.20 | 374.75 | 151.40 | 59.52 |
| Change | -0.0700 | -2.25 | -0.75 | +0.28 | -0.84 |
| % Change | -4.27% | -1.09% | -0.20% | +0.19% | -1.40% |
| Volume | 41,400 | 1,592,681 | 2,911,600 | 6,986,800 | 7,219,255 |
| 20-Day Average Volume | 95,400 | 2,907,065 | 3,021,630 | 8,419,005 | 6,736,315 |
| Previous Close | 1.6400 | 206.45 | 375.50 | 151.12 | 60.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5900 | 194.51 | 361.01 | 147.11 | 56.06 |
| 20-Day Raw Stochastic | 39.81% | 71.47% | 77.96% | 77.60% | 83.43% |
| 20-Day Relative Strength | 43.39 | 61.52 | 62.17 | 63.79 | 68.19 |
| Weighted Alpha | -76.40 | +46.18 | +32.38 | +48.00 | +74.00 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 64% Buy | 88% Buy | 96% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.08% since 02/12/26 | -0.16% since 02/12/26 | +2.33% since 02/12/26 | -0.27% since 02/12/26 | +1.67% since 02/12/26 |
| Low | 1.4000 on 02/18/26 | 204.05 on 02/20/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 58.56 on 02/13/26 |
| High | 1.6400 on 02/19/26 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | -0.63% since 01/20/26 | +13.52% since 01/20/26 | +13.22% since 01/20/26 | +21.96% since 01/20/26 | +24.91% since 01/20/26 |
| Low | 1.4000 on 02/18/26 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 47.77 on 01/21/26 |
| High | 1.8500 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | -35.39% since 11/20/25 | +15.13% since 11/20/25 | +11.51% since 11/20/25 | +21.13% since 11/20/25 | +29.08% since 11/20/25 |
| Low | 1.4000 on 02/18/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 46.47 on 11/21/25 |
| High | 2.7700 on 12/08/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -57.24% since 08/20/25 | +26.80% since 08/20/25 | +26.41% since 08/20/25 | +27.52% since 08/20/25 | +48.54% since 08/20/25 |
| Low | 1.4000 on 02/18/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 4.1200 on 08/22/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,094 | 323,550,432 | 202,420,032 | 187,491,552 | 124,037,000 |
| Shares Outstanding, K | 6,155 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -13,950,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -1,740,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 0.56 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 08/14/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 03/02/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.38 | 18.74 | 13.54 |